Our current data showed that knocking out PRKD3 led to the reduction of p‐ERK1, p‐c‐MYC (Ser62), total c‐MYC and the down‐regulated expression of c‐MYC target genes in breast cancer cells. This evidence concerns the gene PRKD3 and breast cancer.